The predictive capacity of various laboratoryindicators for CSA-AKI were assessed, including tumor necrosisfactor-α (TNF-α), interleukin 2, interleukin 6, and neutrophilgelatinase-associated lipocalin (NGAL). This evidence concerns the gene LCN2 and acute kidney injury.